Replies to post #9611 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Is the posting of [Kamada’s] news simply a prudent and valuable continuation of the "keeping track of the competition" strategy, or are you posting it because it might have more immediate relevance to GTC's stock price or ongoing partnership discussions?<

The former.

[genisi]

Don't shoot but I am the competitor :-)

Seriously, I follow lots of Israeli bio companies and Kamada is one of them.